Tenaya Therapeutics, Inc. (TNYA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $100.55M | +2225.9% |
| 2024 | $4.32M | -90.5% |
| 2023 | $45.68M | -52.1% |
| 2022 | $95.27M | +149.9% |
| 2021 | $38.13M | -70.3% |
| 2020 | $128.53M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $100.55M | +2225.9% |
| 2024 | $4.32M | -90.5% |
| 2023 | $45.68M | -52.1% |
| 2022 | $95.27M | +149.9% |
| 2021 | $38.13M | -70.3% |
| 2020 | $128.53M | — |